当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:46.55亿  总市值:48.85亿
流通股本:4.75亿   总股本:4.98亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.07亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益127782.93万元,未分配利润-67348.04万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产198945.36万元,负债71162.43万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入816,848,135.12533,797,976.84261,261,312.24970,204,758.8
营业总成本815,922,997.79513,553,112.14260,328,377.291,031,638,143.67
其他经营收益
营业利润13,928,933.1231,671,672.699,366,855.16-216,837,181.52
利润总额14,749,487.432,110,947.089,323,669.29-231,643,863
净利润7,162,056.6525,345,366.236,623,398.35-226,512,315.17
每股收益
其他综合收益-2,279,583.73-374,978.77-272,754.983,689,524.72
综合收益总额4,882,472.9224,970,387.466,350,643.37-222,822,790.45
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计697,464,429.81680,417,089.77645,941,574.54644,069,184.3
非流动资产:
非流动资产合计1,291,989,135.871,300,169,768.431,341,121,583.271,351,738,784.96
资产总计1,989,453,565.681,980,586,858.21,987,063,157.811,995,807,969.26
流动负债:
流动负债合计332,734,971.55343,418,505.78333,746,540.5346,697,976.55
非流动负债:
非流动负债合计378,889,306.57374,888,002.33408,903,156.39411,047,175.16
负债合计711,624,278.12718,306,508.11742,649,696.89757,745,151.71
所有者权益(或股东权益):
归属于母公司股东权益合计1,253,557,011.181,238,115,581.31,220,230,623.221,213,861,296.55
股东权益合计1,277,829,287.561,262,280,350.091,244,413,460.921,238,062,817.55
负债和股东权益合计1,989,453,565.681,980,586,858.21,987,063,157.811,995,807,969.26
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计865,049,401.47583,016,858.73257,944,775.861,073,629,719.51
经营活动现金流出小计744,814,231.35517,681,774.34247,886,029.1905,422,428.43
经营活动产生的现金流量净额120,235,170.1265,335,084.3910,058,746.76168,207,291.08
投资活动产生的现金流量:
投资活动现金流入小计79,401,101.0861,612,910.81632,530.327,221,215.11
投资活动现金流出小计133,887,076.1289,818,772.9511,982,154.4274,889,662.07
投资活动产生的现金流量净额-54,485,975.04-28,205,862.14-11,349,624.1-67,668,446.96
筹资活动产生的现金流量:
筹资活动现金流入小计40,300,00036,300,000-58,450,000
筹资活动现金流出小计105,352,877.9786,109,221.3419,430,180.29144,886,348.34
筹资活动产生的现金流量净额-65,052,877.97-49,809,221.34-19,430,180.29-86,436,348.34
汇率变动对现金及现金等价物的影响-1,754,786.44633,349.4314,695.077,117,000.81
现金及现金等价物净增加额-1,058,469.33-12,046,649.69-20,406,362.5621,219,496.59
期末现金及现金等价物余额362,390,402.47351,402,222.11343,000,036.81363,448,871.8
补充资料:
现金及现金等价物的净增加额--12,046,649.69-21,219,496.59
TOP↑